Refining the Use of Adjuvant Oxaliplatin in Clinical Stage II or III Rectal Adenocarcinoma

BACKGROUND. Current guidelines include the use of adjuvant oxaliplatin in clinical stage II or III rectal adenocarcinoma. However, its efficacy is supported by a single phase II trial. We aimed to examine whether oxaliplatin confers survival benefit in this patient population. METHODS. Using the Nat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Oncologist
Prif Awduron: Margalit, Ofer, Mamtani, Ronac, Kopetz, Scott, Yang, Yu‐Xiao, Lawrence, Yaacov R., Abu‐Gazala, Samir, Reiss, Kim A., Golan, Talia, Halpern, Naama, Aderka, Dan, Giantonio, Bruce, Shacham‐Shmueli, Einat, Boursi, Ben
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley & Sons, Inc. 2019
Pynciau:
Gastrointestinal Cancer
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693732/
https://ncbi.nlm.nih.gov/pubmed/30696723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0333
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg